ZENOTECH LABORATORIES
|
The Current P/E Ratio of ZENOTECH LABORATORIES is 70.57.
Share Price | ₹64.3 | Jul 01,2025 |
Market Cap | ₹392.4 Cr | |
Earnings-TTM | ₹5.6 Cr | TTM-Standalone Results |
Price/Earnings | 70.57x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ZENOTECH LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹392.4 Cr] as on Jul 01,2025
(/) Earnings [ ₹5.6 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 70.57x ]
Thus, for ZENOTECH LABORATORIES , the investors are currently willing to pay 70.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZENOTECH LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZENOTECH LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZENOTECH LABORATORIES
PE Ratio Performance Analysis for ZENOTECH LABORATORIES
- ZENOTECH LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.09x.
- ZENOTECH LABORATORIES 's operated at median p/e ratio of 13.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZENOTECH LABORATORIES 's p/e ratio peaked in Mar2024 at 43.47x.
- ZENOTECH LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does ZENOTECH LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ZENOTECH LABORATORIES | 5.56 | 70.57 | 392.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.43 | 400,017.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 83.01 | 181,867.0 |
CIPLA LTD | 5,291.05 | 23.14 | 122,451.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.50 | 115,620.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.69 | 106,572.0 |
MANKIND PHARMA LTD | 2,003.22 | 47.16 | 94,465.4 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.84 | 100,769.0 |
LUPIN LTD | 3,306.26 | 27.09 | 89,575.7 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.71 | 65,775.8 |
ABBOTT INDIA LTD | 1,414.44 | 52.13 | 73,729.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZENOTECH LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.69x |
Max industry PE | 83.01x |
Median industry PE | 36.43x |
Average industry PE | 41.75x |
You may also like the below Video Courses